Contract Service Directory

Pierre Fabre Medicament - SuperCritical Fluids Division





Company Headquarters

16 rue Jean Rostand
Gaillac, Tarn 81600
France

Contract Service Directory

    Related Content

    • BIOSIMILARS: Global Terminology, Strategy & Pathways

      BIOSIMILARS: Global Terminology, Strategy & Pathways

      Download the Global Terminology, Strategy & Pathways Poster

    • Breaking News | Drug Development | Industry News | Preclinical Outsourcing
      Pierre Fabre Buys Igenica Immuno-oncology Assets

      Pierre Fabre Buys Igenica Immuno-oncology Assets

      Deal reinforces Pierre Fabre’s pipeline in oncology, its primary R&D focus area
      05.24.17

    • Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments | Solid Dosage/Semi-solids
      Recro Gainesville Expands Mfg. Capabilities

      Recro Gainesville Expands Mfg. Capabilities

      Installs new tableting equipment and grows development team
      05.24.17


    • Industry News
      Tekni-Plex Acquires BrunaSeals

      Tekni-Plex Acquires BrunaSeals

      Expands closure liner business
      05.23.17

    • APIs

    • Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery

      Pierre Fabre in ADC Collaborative Project

      Aims to discover and develop antibodies drug conjugates against oncology targets
      07.08.16


    • APIs | Breaking News | Drug Discovery | Facilities | Industry News

      Evotec and Pierre Fabre Partner

      Sign multi-year compound management agreement
      04.19.16

    • Collaborations & Alliances | Drug Discovery | Information Technology | Laboratory Testing

      Plasticell, Pierre Fabre Ink Discovery Alliance

      Aims to identify natural stimulants of brown fat to treat obesity and diabetes
      02.23.16

    • Collaborations & Alliances | Drug Discovery | Laboratory Testing | Logistics

      BioAscent, Pierre Fabre in Compound Management Pact

      Establishes central hub for storage and logistics of extensive plant extracts collection
      01.20.16


    • APIs | Breaking News | Capsules | Clinical Trials | Collaborations & Alliances | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Lyophilization | Process Development

      ADVENTRX, Pierre Fabre in Multi-year Manufacturing Pact

      PF to produce API for trials
      06.12.12

    • Breaking News | Collaborations & Alliances

      Pierre Fabre, Forest Labs Enter Depression Drug Pact

      Forest Laboratories, Inc. and Pierre Fabre Medicament have entered into a definitive collaboration agreement to develop and commercialize F2695 in the U.S. and Canada. F2695 is a selective norepinephrine and serotonin reuptake inhibitor being develop…
      12.23.08

    • Breaking News | Industry News

      Pierre Fabre, Zambon Sign Commercial Pact

      Pierre Fabre Medicament of France and Zambon S.p.A. of Italy have successfully executed an agreement, signed February 15, 2007, giving Pierre Fabre commercial rights to Zambon’s product portfolio in Germany.  The strategic partnership…
      02.21.07